How a pharmacist-driven termination protocol effectively reduced the inappropriate use of acid-suppressive medications, with little impact on pharmacist workflow.

Administering oncology medications has shifted from the inpatient to the outpatient setting because of new, minimal-toxicity regimens, rising drug costs, and a movement toward value-based care. As payer reimbursements decrease, healthcare organizations must find ways to reduce costs while maintaining high-quality services.

Using chloral hydrate carries a risk of adverse events and compounding errors, and much of the available literature recommends using alternative sedatives for pediatric patients. But evidence regarding the efficacy of chloral hydrate and of alternative agents is conflicting.

Perseris: A new, long-acting, atypical antipsychotic drug-delivery system